This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
200
Participants in the intervention group will use the AI-personalized version of the Medilepsy® app, which includes a Smart Chatbot that delivers interactive support based on user-entered data. The chatbot offers personalized prompts, relevant topic suggestions, and adaptive educational content to support epilepsy self-management.
Participants in the non-intervention group will use a standard version of the Medilepsy® app without AI functionality. This version includes static prompts and general educational links but does not provide personalized feedback or adaptive interaction.
Orlando Health Arnold Palmer Hospital
Orlando, Florida, United States
RECRUITINGOrlando Health Orlando Regional Medical Center
Orlando, Florida, United States
RECRUITINGExamine the effect of Medilepsy® with and without responsible AI design on medication adherence.
Participants will demonstrate significant improvement in medication adherence measured by Medication adherence rate (MAR) formula: The average number of missed medications. Adherence Rate (%) = (Number of prescribed ASM doses taken / Number of prescribed ASM doses scheduled) × 100.
Time frame: 3-6 months
Examine the effect of Medilepsy® with and without responsible AI design on transition readiness skills.
Participants will demonstrate significant improvement in transition readiness measured by Transition Readiness Assessment Questionnaire (TRAQ) scores: A validated tool/ 5-point Likert scale measuring transition skills across five domains: managing medications, appointment keeping, tracking health issues, communicating with providers, and managing daily activities.
Time frame: 3-6 months
Evaluate the usability of Medilepsy® at study completion.
Participants usability score will be greater than 83% out of 0-100% measured by MHealth App Usability Questionnaire (MAUQ) scores: A validated tool consists of 18 questions rated on a 7-point Likert scale assessing ease of use, usefulness, interface quality, and satisfaction. Higher scores indicate better usability.
Time frame: 3-6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.